Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Microb Pathog ; 114: 95-98, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29180294

RESUMEN

Bovine neonatal diarrhea is common due low immunity in newborn calves, poor management (or absence) of sanitary barriers, and other factors. Newborn calves with diarrhea in the first days of life suffer failure to thrive and may die if left untreated. The aim of this study was to evaluate whether prophylactic administration of a homeopathic product (Dia 100®) can control bovine neonatal diarrhea in calves born on a farm with substantial sanitary challenges. We counted total bacteria and protozoan parasites in fecal samples. We measured serum glucose, total protein, globulin, albumin, cholesterol and triglycerides on days 1, 7 and 14 of life. Twenty newborn calves were maintained in individual stalls, and were divided in two groups: ten untreated animals (control) and ten animals treated with Dia 100®. Fecal consistency was evaluated daily. We diagnosed diarrhea in five animals in the treated group, and in all animals from the control group. Infections with Escherichia coli and Giardia duodenalis were identified as the responsible organisms. The E. coli count was low in the treatment group on day 7 of life compared with the control group. Antibiotics were given to eight animals in the control group, and to two animals in the treatment group. On day of life 7, serum levels of total protein and globulins were higher in the control group, but were lower on day 14. Serum levels of glucose and triglycerides were greater in treated animals on days 7 and 14, suggesting that the homeopathic product contributes to improvement of intestinal health and absorption and nutrients. We conclude that Dia 100® controls diarrhea with 50% of efficacy, and reduces antibiotic utilization.


Asunto(s)
Infecciones Bacterianas/microbiología , Infecciones Bacterianas/veterinaria , Enfermedades de los Bovinos/tratamiento farmacológico , Enfermedades de los Bovinos/prevención & control , Diarrea/tratamiento farmacológico , Diarrea/prevención & control , Diarrea/veterinaria , Animales , Animales Recién Nacidos , Antibacterianos/uso terapéutico , Glucemia/análisis , Proteínas Sanguíneas/análisis , Brasil , Bovinos , Enfermedades de los Bovinos/microbiología , Colesterol/sangre , Escherichia coli/aislamiento & purificación , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Infecciones por Escherichia coli/veterinaria , Heces/microbiología , Heces/parasitología , Giardia lamblia/aislamiento & purificación , Giardia lamblia/patogenicidad , Giardiasis/tratamiento farmacológico , Giardiasis/parasitología , Giardiasis/prevención & control , Giardiasis/veterinaria , Intestinos , Infecciones por Protozoos/tratamiento farmacológico , Infecciones por Protozoos/parasitología , Infecciones por Protozoos/prevención & control , Albúmina Sérica/análisis , Seroglobulinas/análisis , Factores de Tiempo , Triglicéridos/sangre
2.
J Environ Pathol Toxicol Oncol ; 30(3): 261-71, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22126619

RESUMEN

Porphyrins have been shown to act as very efficient photosensitizing agents against a broad number of microbial pathogens, including bacteria, fungi, and protozoa. This property has promising applications at a clinical level for the treatment of infectious diseases by photodynamic therapy. Moreover, this technique is also being used to address environmental problems of high significance, such as the decontamination of wastewaters, the disinfection of fish-farming tanks, the protection of animal species (e.g., amphibians and reptiles) that are endangered by pathogens whose life cycle takes place largely in aqueous media, and the control of populations of noxious insects. Such diversified applications take advantage of the availability of a truly large number of porphyrin derivatives with chemical structures that can be tailored to comply with the physical and chemical properties as well as the biological features of several milieus. In addition, the property typical of porphyrins to absorb essentially all of the wavelengths in the sun emission spectrum allows the promotion of processes largely based on natural resources with significant energy savings and low impact on ecosystems.


Asunto(s)
Infecciones Bacterianas/prevención & control , Micosis/prevención & control , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Infecciones por Protozoos/prevención & control , Contaminantes del Agua/efectos adversos , Animales , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/etiología , Biodiversidad , Desinfección , Ecosistema , Humanos , Insectos , Micosis/tratamiento farmacológico , Micosis/etiología , Porfirinas/uso terapéutico , Infecciones por Protozoos/tratamiento farmacológico , Infecciones por Protozoos/etiología
3.
Int J Infect Dis ; 14(9): e732-8, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20399129

RESUMEN

Intestinal parasite infections have been known to compromise the quality of human life since prehistoric times. Throughout the ages, human civilizations have fought against parasitism, including intestinal parasites. During the second half of the last century, the focus of disease-combating efforts moved to other imminent public health issues, under the notion that the fight against infectious diseases had been won. However, the disease incidence data indicate that these diseases continue to wreak havoc on human productivity across the globe. Lately, chemotherapeutic intervention has been stressed for the control of intestinal parasitic infections. In this paper we evaluate the need for a holistic approach to address this issue and make recommendations for this cause.


Asunto(s)
Antiparasitarios/uso terapéutico , Desinfección de las Manos/métodos , Helmintiasis/prevención & control , Parasitosis Intestinales/prevención & control , Infecciones por Protozoos/prevención & control , Animales , Antiparasitarios/farmacología , Educación en Salud/métodos , Helmintiasis/tratamiento farmacológico , Helmintiasis/parasitología , Humanos , Higiene , Incidencia , Parasitosis Intestinales/tratamiento farmacológico , Parasitosis Intestinales/epidemiología , Parasitosis Intestinales/parasitología , Infecciones por Protozoos/tratamiento farmacológico , Infecciones por Protozoos/parasitología
4.
J Pediatr Gastroenterol Nutr ; 50(3): 309-15, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20038852

RESUMEN

BACKGROUND: This study evaluates the effects of retinol on intestinal barrier function, growth, total parasites, and Giardia spp infections in children in northeastern Brazil. SUBJECTS AND METHODS: The study was a double-blind, randomized placebo-controlled trial (http://clinicaltrials.gov; register no. #NCT00133406) involving 79 children who received vitamin A 100,000-200,000 IU (n = 39) or placebo (n = 40) at enrollment, 4, and 8 months and were followed for 36 months. Intestinal barrier function was evaluated using the lactulose:mannitol ratio test. Stool lactoferrin was used as a marker for intestinal inflammation. RESULTS: The groups were similar with regard to age, sex, nutritional parameters (z scores), serum retinol concentrations, proportion of lactoferrin-positive stool samples, and intestinal barrier function. The lactulose:mannitol ratio did not change during the same time of follow-up (P > 0.05). The proportion of lactoferrin-positive samples evaluated at 1 month did not change between groups (P > 0.05). Total intestinal parasitic, specifically new, infections were significantly lower in the vitamin A treatment compared with control group; these were accounted for entirely by significantly fewer new Giardia infections in the vitamin A treatment group. The cumulative z scores for weight-for-length or height, length or height-for-age z scores, and weight-for-age did not change significantly with vitamin A intervention for 36 months of follow-up. CONCLUSIONS: These data showed that total parasitic infection and Giardia spp infections were significantly lower in the vitamin A treatment group when compared with the placebo group, suggesting that vitamin A improves the host's defenses against Giardia infections.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Suplementos Dietéticos , Giardiasis/prevención & control , Crecimiento/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Vitamina A/uso terapéutico , Vitaminas/uso terapéutico , Adyuvantes Inmunológicos/farmacología , Biomarcadores , Niño , Preescolar , Método Doble Ciego , Heces , Femenino , Giardiasis/parasitología , Humanos , Inflamación/metabolismo , Mucosa Intestinal/parasitología , Mucosa Intestinal/fisiopatología , Lactoferrina/metabolismo , Masculino , Infecciones por Protozoos/parasitología , Infecciones por Protozoos/prevención & control , Vitamina A/farmacología , Vitaminas/farmacología
6.
Expert Opin Biol Ther ; 4(7): 1129-38, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15268679

RESUMEN

Toll-like receptor (TLR) agonists are being developed for use as vaccine adjuvants and as stand-alone immunomodulators because of their ability to stimulate innate and adaptive immune responses. Among the most thoroughly studied TLR agonists are the lipid A molecules that target the TLR4 complex. One promising candidate, monophosphoryl lipid A, which is a derivative of lipid A from Salmonella minnesota, has proven to be safe and effective as a vaccine adjuvant in > 120,000 human doses. A new class of synthetic lipid A mimetics, the aminoalkyl glucosaminide 4-phosphates (AGPs), have been engineered specifically to target human TLR4 and are showing promise as vaccine adjuvants and as monotherapeutic agents capable of eliciting nonspecific protection against a wide range of infectious pathogens. In this review, the authors provide an update of the preclinical and clinical experiences with the TLR4 agonists, MPL (Corixa Corporation) adjuvant and the AGPs.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Factores Inmunológicos/uso terapéutico , Lípido A/análogos & derivados , Glicoproteínas de Membrana/agonistas , Receptores de Superficie Celular/agonistas , Virosis/tratamiento farmacológico , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/química , Adyuvantes Inmunológicos/farmacología , Anciano , Animales , Antivirales/administración & dosificación , Antivirales/química , Antivirales/farmacología , Antivirales/uso terapéutico , Infecciones Bacterianas/inmunología , Infecciones Bacterianas/prevención & control , Vacunas Bacterianas/administración & dosificación , Niño , Ensayos Clínicos como Asunto , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Femenino , Glucolípidos/química , Glucolípidos/inmunología , Glucolípidos/uso terapéutico , Humanos , Factores Inmunológicos/administración & dosificación , Factores Inmunológicos/química , Factores Inmunológicos/farmacología , Lípido A/administración & dosificación , Lípido A/química , Lípido A/inmunología , Lípido A/farmacología , Lípido A/uso terapéutico , Activación de Linfocitos/efectos de los fármacos , Masculino , Glicoproteínas de Membrana/fisiología , Ratones , Ratones Endogámicos BALB C , Estructura Molecular , Infecciones por Protozoos/tratamiento farmacológico , Infecciones por Protozoos/prevención & control , Receptores de Superficie Celular/fisiología , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitiales Respiratorios/efectos de los fármacos , Virus Sincitiales Respiratorios/fisiología , Receptor Toll-Like 4 , Receptores Toll-Like , Vacunas Virales/administración & dosificación , Virosis/inmunología , Virosis/prevención & control , Replicación Viral/efectos de los fármacos
8.
Physiol Behav ; 56(6): 1209-16, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7878093

RESUMEN

Bitter principles and related constituents have been isolated from Vernonia amygdalina (Compositae), a plant ingested by wild chimpanzees sometimes suffering from parasite-related diseases in the Mahale Mountains National Park, Tanzania. These isolated constituents were the known sesquiterpene lactones (vernodalin, vernolide, hydroxyvernolide), and new stigmastane-type steroid glucosides (vernonioside A1-A4: for bitter tasting constituents and vernonioside B1-B3; for nonbitter related constituents). Antiparasitic activity tests of these constituents together with quantitative analyses of the major active constituents, vernodalin and vernonioside B1, supported the hypothesis that Mahale chimpanzees control parasite-related diseases by ingesting the pith of this plant, found to contain several steroid-related constituents. While the major active steroid-related constituents (vernonioside B1 and its primary aglycone, vernoniol B1) do not taste bitter themselves, it was hypothesized that the highly bitter constituents including vernodalin may play an important role as signals to the ingester guiding their choice of the appropriate plant, plant part, and possibly also as signals which help to control the amount of intake.


Asunto(s)
Preferencias Alimentarias/fisiología , Pan troglodytes/fisiología , Plantas Medicinales , Gusto/fisiología , Animales , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Plantas Medicinales/química , Infecciones por Protozoos/prevención & control , Infecciones Protozoarias en Animales , Relación Estructura-Actividad , Tanzanía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA